Skip to main content

Innovative Biosensors Nets $3.5M in Series A to Develop Pathogen Detectors

NEW YORK, May 27 (GenomeWeb News) - Innovative Biosensors has raised $3.5 million of venture capital in a Series A round, the College Park, Md.-based company said yesterday.

 

The company, founded in 2003, uses technology licensed from the Massachusetts Institute of Technology to develop sensitive and fast pathogen detectors for food testing and clinical diagnostics.

 

Harbert Venture Partners led the financing round and was joined by New Markets Growth Fund and the Maryland Venture Fund.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.